Gurit Holding AG logo

Gurit Holding AG (GVM0)

Market Closed
21 Aug, 20:00
XMUN XMUN
30. 40
+0.05
+0.1647%
- Market Cap
80.8 P/E Ratio
2% Div Yield
0 Volume
45.62 Eps
30.35
Previous Close
Add Transaction
Day Range
30.4 30.4
Year Range
11.04 47
Want to track GVM0 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

GVM0 closed yesterday higher at €30.4, an increase of 0.1647% from Thursday's close, completing a monthly increase of 1.1647% or €0.35. Over the past 12 months, GVM0 stock gained 145.1613%.
GVM0 pays dividends to its shareholders, with the most recent payment made on Apr 29, 2024.
Gurit Holding AG has completed 1 stock splits, with the recent split occurring on May 02, 2022.
The company's stock is traded on one exchange.

GVM0 Chart

Gurit Holding AG (GVM0) FAQ

What is the stock price today?

The current price is €30.40.

On which exchange is it traded?

Gurit Holding AG is listed on XMUN.

What is its stock symbol?

The ticker symbol is GVM0.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2%.

What is its market cap?

As of today, no market cap data is available.

Has Gurit Holding AG ever had a stock split?

Gurit Holding AG had 1 splits and the recent split was on May 02, 2022.

Gurit Holding AG Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Javier Perez Freije CEO
XMUN Exchange
- ISIN
Switzerland Country
2,291 Employees
- Last Dividend
2 May 2022 Last Split
- IPO Date

Overview

Mankind Pharma Limited is a prestigious entity in the pharmaceutical sector, with a focus on developing, manufacturing, and marketing an extensive range of pharmaceutical formulations and consumer healthcare products. With its roots firmly established in 1986 in New Delhi, India, the company has expanded its reach both nationally and internationally. Mankind Pharma's commitment to health extends beyond borders, covering a wide array of therapeutic areas that include acute and chronic conditions. It prides itself on being a leading provider of a variety of healthcare solutions, catering to diverse medical needs and ensuring wellness is accessible to all.

Products and Services

  • Pharmaceuticals: Mankind Pharma is renowned for its extensive portfolio of pharmaceutical products catering to various therapeutic domains such as anti-infective, cardiovascular, gastrointestinal, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, and respiratory diseases. The company's dedication to quality and innovation ensures that each product meets the highest standards of safety and efficacy, addressing the complex needs of patients suffering from acute and chronic conditions.
  • Consumer Healthcare Products: Beyond conventional pharmaceuticals, Mankind Pharma offers a broad spectrum of consumer healthcare products. This range includes condoms under the brand Manforce, designed for safer sexual health; Prega News for pregnancy detection; emergency contraceptives like Unwanted-72 to provide options for women; Gas-O-Fas for relief from digestive issues; Health OK, a supplement for overall health; and AcneStar for skincare. Each product is developed with the consumer's health and well-being in mind, offering quality solutions for everyday health care needs.
  • Other Ventures: Mankind Pharma's business interests also extend into trading and exporting of pharmaceutical and healthcare products, underscoring its global vision. The company is involved in the manufacture of packing materials and ayurvedic products, highlighting its commitment to embracing traditional and alternative healthcare solutions. Furthermore, Mankind Pharma ventures into real estate, leasing, and hospitality, diversifying its portfolio while maintaining its core focus on health and wellness. The provision of IT services signifies the company's adaptation to digital advances, ensuring efficiency and modernization in its operations.

Contact Information

Address: Ebnaterstrasse 79
Phone: +44 20 7355 9810